Editor’s Note, SGLT-2 Inhibitor Special Edition, September 2014

As new medications for diabetes come to market there is always a question as to how well they will work when added to other medications.

This month, we have a slide presentation from the ADA, outlining the rationale for mating DPP-4 inhibitors with SGLT-2 inhibitors.